|
2024
|
Invention
|
Pain treating compounds and uses thereof.
The present invention relates to compounds useful in t... |
|
2023
|
Invention
|
Method of treating social anxiety disorder with bnc210. The present invention relates to methods ... |
|
2022
|
Invention
|
Modulators of ion channel receptors and uses thereof. Compounds useful in the modulation of ion c... |
|
2020
|
Invention
|
Pharmaceutical combination and uses thereof.
The invention relates to pharmaceutical combination... |
|
|
Invention
|
Therapeutic formulations and uses thereof.
This invention relates to formulations of compound (I... |
|
|
Invention
|
Therapeutic formulations and uses thereof. This invention relates to formulations of compound (I)... |
|
2019
|
Invention
|
Combination therapy for treating proliferative diseases.
The present invention relates generally... |
|
|
Invention
|
Substituted-n-heteroaryl compounds and uses thereof. Activators of Kv3.1 and/or Kv3.2 channels wh... |
|
|
Invention
|
Substituted-n-heteroaryl compounds and uses thereof. The present disclosure relates generally to ... |
|
|
Invention
|
Cyclic compounds as receptor modulating therapeutics and methods and uses thereof.
The present i... |
|
|
Invention
|
Cyclic compounds as receptor modulating therapeutics and methods and uses thereof. The present in... |
|
|
Invention
|
Substituted-pyridinyl compounds and uses thereof. The present application relates generally to co... |
|
|
Invention
|
Pain treating compounds and uses thereof. The present invention relates to compounds useful in th... |
|
|
Invention
|
Modulators of ion channel receptors and uses thereof. The present invention relates to compounds ... |
|
|
Invention
|
Method of monitoring response to a treatment.
The present invention relates to the field of phar... |
|
|
Invention
|
Method of monitoring response to a treatment. The present invention relates to the field of pharm... |
|
2018
|
Invention
|
Therapeutic compounds and uses thereof. The present invention relates to compounds useful in the ... |
|
|
Invention
|
Methods of treating agitation. The present disclosure relates generally to the treatment of agita... |
|
|
Invention
|
Isoxazolyl compounds as receptor modulating compounds and methods and uses thereof.
The present ... |
|
|
Invention
|
Isoxazolyl compounds as receptor modulating compounds and methods and uses thereof. The present i... |
|
|
Invention
|
Method for treating acute myeloid leukemia. The present invention relates to a method for the tre... |
|
|
Invention
|
Amine derivatives as potassium channel blockers.
The present invention relates to compounds usef... |
|
2017
|
Invention
|
Anxiolytic compounds. The present invention relates to chemical compounds of general formula (I):... |
|
|
Invention
|
Anxiolytic compounds. The present invention relates to chemical compounds of general formula (I)
... |
|
|
Invention
|
Modulators of nicotinic acetylcholine receptors and uses thereof. The present invention relates g... |
|
|
Invention
|
Antibody and checkpoint inhibitor combination therapy. The present invention provides a combinati... |
|
|
Invention
|
Salts, co-crystals, and polymorphs of an anxiolytic compound. The present invention provides crys... |
|
|
Invention
|
Crystalline form of an anxiolytic compound.
The present invention provides a crystalline Form B ... |
|
|
Invention
|
Antibody drug conjugates that bind lgr5.
Embodiments of the methods and compositions provided he... |
|
|
Invention
|
Administration of an anti-lgr5 monoclonal antibody. The present invention relates generally to th... |
|
2016
|
Invention
|
Amine derivatives as potassium channel blockers. The present invention relates to compounds usefu... |
|
|
Invention
|
Pharmaceutical combination and uses thereof. The invention relates to pharmaceutical combinations... |
|
|
Invention
|
Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin ... |
|
|
Invention
|
Combination treatment protocol. The present disclosure provides a combination and a method for tr... |
|
2015
|
Invention
|
Predictive biomarkers. The present disclosure relates to the biological markers SAP, SHBG, Myoglo... |
|
|
Invention
|
Predictive baseline biomarkers for use of vascular disrupting agents. The present disclosure rela... |
|
|
Invention
|
Predicting response to cancer therapy. The present invention relates to cancer markers that are p... |
|
2014
|
Invention
|
A therapeutic protocol for treating ovarian cancer.
The present invention is directed to a pharm... |
|
|
Invention
|
Method for treating chronic lymphocytic leukemia. The present disclosure provides methods for tre... |
